RhoA with Associated TRAb or FT3 in the Diagnosis and Prediction of Graves’ Ophthalmopathy

Table 2

Correlation coefficients and diagnostic significance of thyroid hormone and related antibodies with GO incidence for the two groups.

Parameters		value	Area under the curve (AUC)	value	Confidence interval of 0.95
					Lower bound	Upper bound
Basal RhoA levels	0.501	0.001	0.795	0.001	0.652	0.938
Endpoint RhoA levels	0.197	0.130	0.616	0.129	0.459	0.774
RhoA difference	-0.527	0.001	0.811	0.001	0.676	0.945
Basal FT3 levels	0.287	0.026	0.669	0.028	0.526	0.812
Endpoint value of FT3	0.109	0.407	0.564	0.402	0.417	0.711
FT3 difference	-0.272	0.035	0.660	0.037	0.513	0.807
Basal FT4 levels	0.163	0.213	0.596	0.210	0.445	0.747
Endpoint value of FT4	0.004	0.976	0.502	0.976	0.346	0.658
FT4 difference	-0.198	0.129	0.617	0.128	0.469	0.764
Basal TSH levels	0.019	0.886	0.508	0.922	0.358	0.657
Endpoint value of TSH	0.073	0.581	0.543	0.577	0.388	0.697
TSH difference	0.080	0.545	0.547	0.541	0.393	0.700
TRAb	0.372	0.003	0.719	0.004	0.592	0.846
TPOAb	0.005	0.970	0.497	0.970	0.346	0.648
TgAb	0.012	0.926	0.507	0.928	0.349	0.665

Statistically significant results are in bold.